Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 Preis auf Anfrage

Artikelnummer: TGM-T9901A-1093
Artikelname: Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 Preis auf Anfrage
Artikelnummer: TGM-T9901A-1093
Hersteller Artikelnummer: T9901A-1093
Alternativnummer: TGM-T9901A-1093-1MG,TGM-T9901A-1093-5MG
Hersteller: TargetMol
Kategorie: Biochemikalien
Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 is an antibody-drug conjugate (ADC) composed of the human-derived anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody Lifastuzumab, linked with the Mc-VC-PAB connector and the topoisomeraseI inhibitor SN38. The ADCs cytotoxic component and linker are Mc-VC-PAB-SN38. This compound is utilized in cancer research.
Target-Kategorie: Antibody-Drug Conjugates (ADCs)|||Topoisomerase|||Sodium Channel